STAT3 and triple-negative breast carcinoma: Figure 14 summarizes the tentatively proposed action mechanism for the anti-proliferative, EMT inhibition, and apoptotic activity of DiMeOC-Mg-BCD against the MDA-MB-231 triple-negative breast cancer cell line. To confirm the role of this compound, which is suggested to inhibit the IL-6/STAT3 action mechanism with subsequent initiation of apoptosis [75], it would be necessary to carry out further experiments such as a Western blot study to detect the participation of proteins involved in the proposed signaling pathway.